CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Treeway B.V. is focused on accelerating research and developing new therapies for amyotrophic lateral sclerosis (ALS). The project aims to create a quick diagnostic tool to improve early diagnosis and monitor treatment efficacy, ultimately speeding up clinical trials and drug development.
The unique Dutch SME Treeway B.V. was founded in 2012 by two highly experienced and successful entrepreneurs that both have been diagnosed with amyotrophic lateral sclerosis (ALS).
It is Treeway’s mission to eradicate ALS from the face of the earth by speeding up ALS research and bringing new therapies in the market as soon as possible.
Treeway already has one new therapy in clinical development, which has recently received EMA’s Orphan Medicinal Product Designation.ALS is a rare disease that is…
TREEWAY B.V.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
